🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to evaluate efficacy and safety of regorafe...
Status
Completed
Location
Multiple Locations
Start Date
2013-05-14
Trial ID
NCT01774344
Treatments Being Tested
60 patients of radiological, biopsy proven advanced HCC (Hepatocellular car...
Status
Completed
Location
Institute of Liver & Biliary Sciences
Start Date
2014-10-01
Trial ID
NCT02259647
CVM-1118 is a new small molecule chemical entity being developed as a poten...
Status
Terminated
Location
Charleston Hematology Oncology Associates
Start Date
2018-07-12
Trial ID
NCT03582618
The incidence rate of pancreatic neuroendocrine neoplasms (pNENs) is increa...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-09-30
Trial ID
NCT06592989
Treatments Being Tested
The purpose of this study is to evaluate the combination of Revlimid® (lena...
Status
Terminated
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2011-05
Trial ID
NCT01348503
Treatments Being Tested
This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Status
Unknown
Location
The First Affiliated Hospital of Sun Yat-sen University
Start Date
2019-09-15
Trial ID
NCT04143191
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
The goal of this clinical research study is to learn if 5-azacitidine and s...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-02-06
Trial ID
NCT02196857
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
Tom Baker Cancer Centre - Calgary
Start Date
2004-08-10
Trial ID
NCT00093457
Treatments Being Tested
To evaluate efficacy and safety of sorafenib versus placebo in the adjuvant...
Status
Completed
Location
Multiple Locations
Start Date
2008-08-15
Trial ID
NCT00692770
Treatments Being Tested